← Eichor
Condition: Extramedullary Multiple Myeloma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Extramedullary Multiple Myeloma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Thera
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06140966Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Mye
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT073827393'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
Phase 1 · 1 location(s) · Beijing GoBroad Hospital · NCT07003568Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
Phase 1 · 1 location(s) · Beijing GoBroad Hospital · NCT07003555Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma
Phase 1/Phase 2 · 1 location(s) · Affiliated Hospital of Nantong University · NCT06246162GR1803 Injection in Patients With RRMM
Phase 2 · 1 location(s) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. · NCT06952075European Myeloma Network (EMN) Sample Project
Phase N/A · 41 location(s) · European Myeloma Network B.V. · NCT06237803Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137643Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM
Phase 1/Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07109323Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedu
NA · 2 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06793475SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease
Phase 2 · 6 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05900882Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients Wit
Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT06627751External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extr
Phase 1/Phase 2 · 1 location(s) · City of Hope Medical Center · NCT06572605
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.